| Interleukin-6 as a therapeutic target in human ovarian cancer J Coward, H Kulbe, P Chakravarty, D Leader, V Vassileva, DA Leinster, ... Clinical cancer research 17 (18), 6083-6096, 2011 | 451 | 2011 |
| Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody–drug conjugate (ADC) JPM Nunes, M Morais, V Vassileva, E Robinson, VS Rajkumar, ... Chemical communications 51 (53), 10624-10627, 2015 | 134 | 2015 |
| Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability V Vassileva, A Millar, L Briollais, W Chapman, B Bapat Cancer research 62 (14), 4095-4099, 2002 | 129 | 2002 |
| Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice G Hartmann, V Vassileva, M Piquette-Miller Drug Metabolism and Disposition 33 (6), 820-828, 2005 | 95 | 2005 |
| Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer V Vassileva, CJ Allen, M Piquette-Miller Molecular Cancer Therapeutics 7 (3), 630-637, 2008 | 91 | 2008 |
| Pyridazinediones deliver potent, stable, targeted and efficacious antibody–drug conjugates (ADCs) with a controlled loading of 4 drugs per antibody E Robinson, JPM Nunes, V Vassileva, A Maruani, JCF Nogueira, ... RSC advances 7 (15), 9073-9077, 2017 | 82 | 2017 |
| In vitro and in vivo characterization of a novel biocompatible polymer–lipid implant system for the sustained delivery of paclitaxel EA Ho, V Vassileva, C Allen, M Piquette-Miller Journal of controlled release 104 (1), 181-191, 2005 | 82 | 2005 |
| Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model V Vassileva, J Grant, R De Souza, C Allen, M Piquette-Miller Cancer chemotherapy and pharmacology 60, 907-914, 2007 | 78 | 2007 |
| Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging V Vassileva, EH Moriyama, R De Souza, J Grant, CJ Allen, BC Wilson, ... British journal of cancer 99 (12), 2037-2043, 2008 | 56 | 2008 |
| Use of a next generation maleimide in combination with THIOMAB™ antibody technology delivers a highly stable, potent and near homogeneous THIOMAB™ antibody-drug conjugate (TDC) JPM Nunes, V Vassileva, E Robinson, M Morais, MEB Smith, RB Pedley, ... RSC advances 7 (40), 24828-24832, 2017 | 53 | 2017 |
| Electrohydrodynamic fabrication of core–shell PLGA nanoparticles with controlled release of cisplatin for enhanced cancer treatment PJT Reardon, M Parhizkar, AH Harker, RJ Browning, V Vassileva, ... International journal of nanomedicine, 3913-3926, 2017 | 47 | 2017 |
| Targeting pyruvate kinase M2 and lactate dehydrogenase a is an effective combination strategy for the treatment of pancreatic cancer GH Mohammad, V Vassileva, P Acedo, SWM Olde Damink, M Malago, ... Cancers 11 (9), 1372, 2019 | 42 | 2019 |
| Tunable semiconducting polymer nanoparticles with INDT-based conjugated polymers for photoacoustic molecular imaging T Stahl, R Bofinger, I Lam, KJ Fallon, P Johnson, O Ogunlade, ... Bioconjugate Chemistry 28 (6), 1734-1740, 2017 | 35 | 2017 |
| Inflammation: Extinguishing the fires within V Vassileva, M Piquette‐Miller Clinical Pharmacology & Therapeutics 87 (4), 375-379, 2010 | 18 | 2010 |
| Significant therapeutic efficacy with combined radioimmunotherapy and cetuximab in preclinical models of colorectal cancer V Vassileva, V Rajkumar, M Mazzantini, M Robson, A Badar, S Sharma, ... Journal of Nuclear Medicine 56 (8), 1239-1245, 2015 | 14 | 2015 |
| Inflammation: the dynamic force of health and disease V Vassileva, M Piquette‐Miller Clinical Pharmacology & Therapeutics 96 (4), 401-405, 2014 | 14 | 2014 |
| Apoptotic and growth regulatory genes as mutational targets in mismatch repair deficient endometrioid adenocarcinomas of young patients V Vassileva, A Millar, L Briollais, W Chapman, B Bapat Oncology reports 11 (4), 931-937, 2004 | 14 | 2004 |
| Evaluation of apoptosis imaging biomarkers in a genetic model of cell death V Vassileva, SM Stribbling, C Barnes, L Carroll, M Braga, J Abrahams, ... EJNMMI research 9, 1-13, 2019 | 10 | 2019 |
| The significance of some prognostic factors on local tumor control in early breast cancer after conservative surgery and radiotherapy L Marinova, J Todorov, I Koleva, V Vassileva JOURNAL-BALKAN UNION OF ONCOLOGY 6, 143-148, 2001 | 7 | 2001 |
| Effective Detection and Monitoring of Glioma Using [18F]FPIA PET Imaging V Vassileva, M Braga, C Barnes, J Przystal, A Ashek, L Allott, D Brickute, ... Biomedicines 9 (7), 811, 2021 | 6 | 2021 |
Stephen CaddickProfessor of Organic Chemistry and Chemical Biology, UCLBestätigte E-Mail-Adresse bei ucl.ac.uk
